The University of Chicago Header Logo

Connection

Elliot Gershon to Middle Aged

Back to Details
This is a "connection" page, showing publications Elliot Gershon has written about Middle Aged.
Elliot Gershon
Connection Strength
0.519
Middle Aged
  1. NRXN1 is associated with enlargement of the temporal horns of the lateral ventricles in psychosis. Transl Psychiatry. 2019 09 17; 9(1):230.
    View in: PubMed
    Score: 0.039
  2. Brain Age Disparities in Psychosis Across DSM Diagnoses and B-SNIP Biotypes. Schizophr Bull. 2026 Jan 16; 52(1).
    View in: PubMed
    Score: 0.015
  3. Evaluating the Exposome Score for Schizophrenia in a Transdiagnostic Psychosis Cohort: Associations With Psychosis Risk, Symptom Severity, and Personality Traits. Schizophr Bull. 2025 Sep 08; 51(5):1454-1463.
    View in: PubMed
    Score: 0.015
  4. The BAsic NeuroCognitive Continuum (BANCC): Delineation of dimensional and categorical features for etiological and treatment investigations of idiopathic psychosis. Psychiatry Clin Neurosci. 2025 Nov; 79(11):747-756.
    View in: PubMed
    Score: 0.015
  5. Differentiating biomarker features and familial characteristics of B-SNIP psychosis Biotypes. Transl Psychiatry. 2025 Aug 14; 15(1):281.
    View in: PubMed
    Score: 0.015
  6. Exposotypes in psychotic disorders. Sci Rep. 2025 Aug 08; 15(1):29003.
    View in: PubMed
    Score: 0.015
  7. Neural fingerprints of data driven cognitive subtypes across the psychosis spectrum: a B-SNIP study. Transl Psychiatry. 2025 Jul 02; 15(1):224.
    View in: PubMed
    Score: 0.015
  8. Impact of Polygenic Interactions With Anticholinergic Burden on Cognition and Brain Structure in Psychosis Spectrum Disorders. Am J Psychiatry. 2025 Aug 01; 182(8):751-762.
    View in: PubMed
    Score: 0.014
  9. White Matter, Cognition, and Electrophysiological Variables in Bipolar Disorder: Using Multimodal Integration of Biomarker Variables Associated With Bipolar Disorder to Elucidate Deficits. Bipolar Disord. 2025 May; 27(3):205-216.
    View in: PubMed
    Score: 0.014
  10. Characterizing the relationship between personality dimensions and psychosis-specific clinical characteristics. Schizophr Res. 2025 Feb; 276:88-96.
    View in: PubMed
    Score: 0.014
  11. Gyrification across psychotic disorders: A bipolar-schizophrenia network of intermediate phenotypes study. Schizophr Res. 2024 09; 271:169-178.
    View in: PubMed
    Score: 0.014
  12. Evidence from comprehensive independent validation studies for smooth pursuit dysfunction as a sensorimotor biomarker for psychosis. Sci Rep. 2024 06 15; 14(1):13859.
    View in: PubMed
    Score: 0.014
  13. Neural Processing of Repeated Emotional Scenes in Schizophrenia, Schizoaffective Disorder, and Bipolar Disorder. Schizophr Bull. 2021 08 21; 47(5):1473-1481.
    View in: PubMed
    Score: 0.011
  14. Biomarker Profiles in Psychosis Risk Groups Within Unaffected Relatives Based on Familiality and Age. Schizophr Bull. 2021 07 08; 47(4):1058-1067.
    View in: PubMed
    Score: 0.011
  15. Regression dynamic causal modeling for resting-state fMRI. Hum Brain Mapp. 2021 05; 42(7):2159-2180.
    View in: PubMed
    Score: 0.011
  16. Brain gray matter network organization in psychotic disorders. Neuropsychopharmacology. 2020 03; 45(4):666-674.
    View in: PubMed
    Score: 0.010
  17. Smooth pursuit eye movement deficits as a biomarker for psychotic features in bipolar disorder-Findings from the PARDIP study. Bipolar Disord. 2020 09; 22(6):602-611.
    View in: PubMed
    Score: 0.010
  18. Electrophysiological correlates of emotional scene processing in bipolar disorder. J Psychiatr Res. 2020 01; 120:83-90.
    View in: PubMed
    Score: 0.010
  19. Characterizing functional regional homogeneity (ReHo) as a B-SNIP psychosis biomarker using traditional and machine learning approaches. Schizophr Res. 2020 01; 215:430-438.
    View in: PubMed
    Score: 0.010
  20. Auditory steady-state EEG response across the schizo-bipolar spectrum. Schizophr Res. 2019 07; 209:218-226.
    View in: PubMed
    Score: 0.009
  21. Shared Genetic Risk of Schizophrenia and Gray Matter Reduction in 6p22.1. Schizophr Bull. 2019 01 01; 45(1):222-232.
    View in: PubMed
    Score: 0.009
  22. Efficient region-based test strategy uncovers genetic risk factors for functional outcome in bipolar disorder. Eur Neuropsychopharmacol. 2019 01; 29(1):156-170.
    View in: PubMed
    Score: 0.009
  23. Alterations in intrinsic fronto-thalamo-parietal connectivity are associated with cognitive control deficits in psychotic disorders. Hum Brain Mapp. 2019 01; 40(1):163-174.
    View in: PubMed
    Score: 0.009
  24. Polygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controls. Transl Psychiatry. 2018 04 12; 8(1):78.
    View in: PubMed
    Score: 0.009
  25. Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia. Transl Psychiatry. 2017 06 20; 7(6):e1155.
    View in: PubMed
    Score: 0.008
  26. Impaired Context Processing is Attributable to Global Neuropsychological Impairment in Schizophrenia and Psychotic Bipolar Disorder. Schizophr Bull. 2017 03 01; 43(2):397-406.
    View in: PubMed
    Score: 0.008
  27. The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample. BMC Psychiatry. 2016 May 05; 16:129.
    View in: PubMed
    Score: 0.008
  28. Polygenic risk for type 2 diabetes mellitus among individuals with psychosis and their relatives. J Psychiatr Res. 2016 Jun; 77:52-8.
    View in: PubMed
    Score: 0.008
  29. Pursuit eye movements as an intermediate phenotype across psychotic disorders: Evidence from the B-SNIP study. Schizophr Res. 2015 Dec; 169(1-3):326-333.
    View in: PubMed
    Score: 0.007
  30. Behavioral response inhibition in psychotic disorders: diagnostic specificity, familiality and relation to generalized cognitive deficit. Schizophr Res. 2014 Nov; 159(2-3):491-8.
    View in: PubMed
    Score: 0.007
  31. Regressing to Prior Response Preference After Set Switching Implicates Striatal Dysfunction Across Psychotic Disorders: Findings From the B-SNIP Study. Schizophr Bull. 2015 Jul; 41(4):940-50.
    View in: PubMed
    Score: 0.007
  32. Emotion recognition deficits in schizophrenia-spectrum disorders and psychotic bipolar disorder: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. Schizophr Res. 2014 Sep; 158(1-3):105-12.
    View in: PubMed
    Score: 0.007
  33. Reduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders. Schizophr Bull. 2014 Nov; 40(6):1374-84.
    View in: PubMed
    Score: 0.007
  34. Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. Am J Psychiatry. 2013 Nov; 170(11):1275-84.
    View in: PubMed
    Score: 0.006
  35. Elevated antisaccade error rate as an intermediate phenotype for psychosis across diagnostic categories. Schizophr Bull. 2014 Sep; 40(5):1011-21.
    View in: PubMed
    Score: 0.006
  36. Linkage of Alzheimer's disease to chromosome 21 and chromosome 19 markers: effect of age of onset assumptions. Genet Epidemiol. 1993; 10(6):449-54.
    View in: PubMed
    Score: 0.006
  37. Neurophysiological evidence of corollary discharge function during vocalization in psychotic patients and their nonpsychotic first-degree relatives. Schizophr Bull. 2013 Nov; 39(6):1272-80.
    View in: PubMed
    Score: 0.006
  38. Two gene co-expression modules differentiate psychotics and controls. Mol Psychiatry. 2013 Dec; 18(12):1308-14.
    View in: PubMed
    Score: 0.006
  39. Genome-wide significant association between a 'negative mood delusions' dimension in bipolar disorder and genetic variation on chromosome 3q26.1. Transl Psychiatry. 2012 Sep 25; 2:e165.
    View in: PubMed
    Score: 0.006
  40. Case-control association study of TGOLN2 in attempted suicide. Am J Med Genet B Neuropsychiatr Genet. 2010 Jul; 153B(5):1016-23.
    View in: PubMed
    Score: 0.005
  41. Genetic control of individual differences in gene-specific methylation in human brain. Am J Hum Genet. 2010 Mar 12; 86(3):411-9.
    View in: PubMed
    Score: 0.005
  42. Genome-wide association study of bipolar disorder in European American and African American individuals. Mol Psychiatry. 2009 Aug; 14(8):755-63.
    View in: PubMed
    Score: 0.005
  43. Measuring cholinergic sensitivity: I. Arecoline effects in bipolar patients. Biol Psychiatry. 1989 Mar 01; 25(5):610-7.
    View in: PubMed
    Score: 0.005
  44. Cytogenetic studies of males with schizophrenia. Screening for the fragile X chromosome and other chromosomal abnormalities. Schizophr Res. 1988 Jul-Aug; 1(4):277-81.
    View in: PubMed
    Score: 0.004
  45. Familial aggregation of postpartum mood symptoms in bipolar disorder pedigrees. Bipolar Disord. 2008 Feb; 10(1):38-44.
    View in: PubMed
    Score: 0.004
  46. Clinical features of illness in siblings with schizophrenia or schizoaffective disorder. Arch Gen Psychiatry. 1987 Oct; 44(10):891-6.
    View in: PubMed
    Score: 0.004
  47. Birth-cohort changes in manic and depressive disorders in relatives of bipolar and schizoaffective patients. Arch Gen Psychiatry. 1987 Apr; 44(4):314-9.
    View in: PubMed
    Score: 0.004
  48. Mood-incongruent psychotic features in bipolar disorder: familial aggregation and suggestive linkage to 2p11-q14 and 13q21-33. Am J Psychiatry. 2007 Feb; 164(2):236-47.
    View in: PubMed
    Score: 0.004
  49. Neuropeptide gene polymorphisms in affective disorder and schizophrenia. J Psychiatr Res. 1987; 21(4):581-7.
    View in: PubMed
    Score: 0.004
  50. Epstein-Barr virus and depression. Arch Gen Psychiatry. 1986 Aug; 43(8):815-6.
    View in: PubMed
    Score: 0.004
  51. Pirbuterol trial as antidepressant. Biol Psychiatry. 1986 May; 21(5-6):565-6.
    View in: PubMed
    Score: 0.004
  52. Neuropeptides in human cerebrospinal fluid. Life Sci. 1985 Sep 30; 37(13):1265-70.
    View in: PubMed
    Score: 0.004
  53. Muscarinic cholinergic receptors on skin fibroblasts in familial affective disorder. N Engl J Med. 1984 Jul 26; 311(4):225-30.
    View in: PubMed
    Score: 0.003
  54. A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Arch Gen Psychiatry. 1982 Oct; 39(10):1157-67.
    View in: PubMed
    Score: 0.003
  55. An effective method for measuring salivary lithium in patients on anticholinergic drugs. Biol Psychiatry. 1982 Oct; 17(10):1145-55.
    View in: PubMed
    Score: 0.003
  56. Red cell ouabain-sensitive Na+-K+-adenosine triphosphatase: a state marker in affective disorder inversely related to plasma cortisol. Biol Psychiatry. 1982 Sep; 17(9):981-92.
    View in: PubMed
    Score: 0.003
  57. A new method for the use of salivary lithium concentrations as an indicator of plasma lithium levels. Biol Psychiatry. 1982 Jan; 17(1):99-102.
    View in: PubMed
    Score: 0.003
  58. Patient and family attitudes about schizophrenia: implications for genetic counseling. Schizophr Bull. 1982; 8(3):504-13.
    View in: PubMed
    Score: 0.003
  59. Comorbid bipolar disorder and panic disorder in families with a high prevalence of bipolar disorder. Am J Psychiatry. 2002 Jan; 159(1):30-5.
    View in: PubMed
    Score: 0.003
  60. The Family Attitudes Questionnaire. Patients' and spouses' views of bipolar illness. Arch Gen Psychiatry. 1981 May; 38(5):562-8.
    View in: PubMed
    Score: 0.003
  61. Monoamine oxidase type A in fibroblasts from patients with bipolar depressive illness. Psychiatry Res. 1980 Jul; 2(3):307-14.
    View in: PubMed
    Score: 0.003
  62. A collaborative study of genetic linkage of bipolar manic-depressive illness and red/green colorblindness. A project of the biological psychiatry collaborative program of the world health organization. Acta Psychiatr Scand. 1980 Apr; 61(4):319-38.
    View in: PubMed
    Score: 0.003
  63. Plasma MAO activity unrelated to genetic vulnerability to primary affective illness. Arch Gen Psychiatry. 1977 Jun; 34(6):731-4.
    View in: PubMed
    Score: 0.002
  64. The question of X-linkage in bipolar manic-depressive illness. J Psychiatr Res. 1977; 13(2):99-117.
    View in: PubMed
    Score: 0.002
  65. Sociocultural and demographic correlates of affective disorders in Jerusalem. J Psychiatr Res. 1975 Apr; 12(1):37-50.
    View in: PubMed
    Score: 0.002
  66. Tics and Tourette's disorder: a 2- to 7-year follow-up of 54 obsessive-compulsive children. Am J Psychiatry. 1992 Sep; 149(9):1244-51.
    View in: PubMed
    Score: 0.001
  67. Hostility and depression. Psychiatry. 1968 Aug; 31(3):224-35.
    View in: PubMed
    Score: 0.001
  68. Psychiatric disorders in the relatives of probands with affective disorders. The Yale University--National Institute of Mental Health Collaborative Study. Arch Gen Psychiatry. 1984 Jan; 41(1):13-21.
    View in: PubMed
    Score: 0.001
  69. Plasma and CSF GABA in affective illness. Br J Psychiatry. 1982 Nov; 141:483-7.
    View in: PubMed
    Score: 0.001
  70. Plasma MHPG in rapid cyclers and healthy twins. Arch Gen Psychiatry. 1981 Nov; 38(11):1287-90.
    View in: PubMed
    Score: 0.001
  71. A comparison of nonpatient and bipolar patient-well spouse couples. Am J Psychiatry. 1981 Jun; 138(6):764-8.
    View in: PubMed
    Score: 0.001
  72. Human leukocyte antigen system not closely linked to or associated with bipolar manic-depressive illness. Biol Psychiatry. 1979 Aug; 14(4):615-36.
    View in: PubMed
    Score: 0.001
  73. The role of plasma amine oxidase, platelet monoamine oxidase, and red cell catechol-O-methyl transferase in severe behavioral reactions to disulfiram. Am J Psychiatry. 1979 May; 136(5):679-84.
    View in: PubMed
    Score: 0.001
  74. Reduced MAO activity in first-degree relatives of individuals with bipolar affective disorders. A preliminary report. Arch Gen Psychiatry. 1977 May; 34(5):601-6.
    View in: PubMed
    Score: 0.001
  75. Heritable factors in the severity of affective illness. Biol Psychiatry. 1976 Feb; 11(1):31-42.
    View in: PubMed
    Score: 0.000
  76. Lithium carbonate response in depression. Prediction by unipolar/bipolar illness, average-evoked response, catechol-O-methyl transferase, and family history. Arch Gen Psychiatry. 1975 Sep; 32(9):1107-11.
    View in: PubMed
    Score: 0.000
  77. Catecholamine metabolism in affective disorders. IV. Preliminary studies of norepinephrine metabolism in depressed patients treated with amitriptyline. J Psychiatr Res. 1972 Sep; 9(3):173-85.
    View in: PubMed
    Score: 0.000
  78. Psychobiological and pharmacological studies of manic-depressive illness. J Psychiatr Res. 1972 Sep; 9(3):207-26.
    View in: PubMed
    Score: 0.000
  79. Excretion of 17-OHCS in unipolar and bipolar depressed patients. Arch Gen Psychiatry. 1972 Apr; 26(4):360-3.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.